Renalytix (LON:RENX) Stock Breaks Above 50-Day Moving Average – What’s Next?

Renalytix Plc (LON:RENX)’s share price passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of GBX 5.47 and traded as high as GBX 5.48. Renalytix shares last traded at GBX 5.48, with a volume of 318,458 shares traded.

Renalytix Stock Performance

The stock has a market capitalization of £36.29 million, a price-to-earnings ratio of -1.35 and a beta of 1.71. The company has a current ratio of 1.57, a quick ratio of 2.42 and a debt-to-equity ratio of -483.33. The stock’s 50 day moving average is GBX 5.47 and its 200 day moving average is GBX 3.59.

Insider Buying and Selling at Renalytix

In related news, insider Christopher H. B. Mills sold 1,166,667 shares of Renalytix stock in a transaction that occurred on Tuesday, September 29th. The stock was sold at an average price of GBX 6, for a total transaction of £70,000.02. 5.99% of the stock is currently owned by company insiders.

Renalytix Company Profile

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com).